MedPath

Topical Application of Silver Nanoparticles and Oral Pathogens in Ill Patients

Not Applicable
Completed
Conditions
Critical Illness
Interventions
Other: placebo
Other: silver nanoparticles
Registration Number
NCT02761525
Lead Sponsor
Universidad Autonoma de San Luis Potosí
Brief Summary

The purpose of this study is to determine whether oral topic silver nanoparticles are effective to reduce potential pathogen microbial loads in mechanical ventilation patients.

Detailed Description

All patients were performed with oral hygiene as recommended by the clinical practice guidelines for the prevention, diagnosis and treatment of pneumonia associated with mechanical ventilation. After that, placed the treatment of an innocuous gel compound with 12ppm of silver nanoparticles or gel alone according to randomization. Then obtain and plant samples taken before the treatment 6 hours after. Comparing the results of the baseline sample with the final.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. Patients with at least 24 hrs application endotracheal tube and ventilator support were nasogastric tube ,in the ICU of Hospital Central "Dr. Ignacio Morones Prieto"
  2. Patients with at least 24 hours of ICU admission.
  3. Sedo - analgesia patients in a coma or induced coma.
  4. Over 15 years old
  5. Informed consent signed by a family member or legal guardian of the patient.
Exclusion Criteria
  1. The patient is not taking part in another study that cause conflict with the present test.
  2. Patients who develop bronchiectasis , severe or massive hemoptysis , cystic fibrosis.
  3. Patients with known sensitivity to silver.
  4. Patients who had reported difficult intubation in the record.
  5. Patients whose physical condition does not allow the completion of the oral examination, proper sampling or application of gel.
  6. Pregnant women
  7. Patients with oral mucositis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboplacebotopic innocuous gel
gel silver nanoparticlessilver nanoparticlestopic gel silver nanoparticles 12 ppm
Primary Outcome Measures
NameTimeMethod
Compare Colony Forming Units after the intervention. Unique dosis.Comparison of microbial colony forming units at 6 hr of treatment with gel application

Before oral hygiene in the intubated patient, it was taken with sterile swab, a saliva sample which was sown in dextrose Sabouraud agar and tryptone soya agar. 6 hours later, placement of the experimental gel, retook saliva sample with a sterile swab and they seeded in the same agars . Colony forming units were counted before and after the intervention using semi-automated colony counter .

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath